Sialoadhesin promotes neuroinflammation‐related disease progression in two mouse models of CLN disease
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
CLN diseases are mostly fatal lysosomal storage diseases that lead to neurodegeneration in the CNS. We have previously shown that CD8+ T‐lymphocytes contribute to axonal perturbation and neuron loss in the CNS of Ppt1−/− mice, a model of CLN1 disease. We now investigated the role of the inflammation‐related cell adhesion molecule sialoadhesin (Sn) in Ppt1−/− and Cln3−/− mice, a model of the most frequent form, CLN3 disease. Microglia/macrophages in the CNS of both models showed an upregulation of Sn and markers for proinflammatory M1 polarization and antigen presentation. Sn+ microglia/macrophages associated with SMI32+ axonal spheroids and CD8+ T‐lymphocytes. To analyze their pathogenic impact, we crossbred both models with Sn‐deficient mice and scored axonal degeneration and neuronal integrity using immunohistochemistry, electron microscopy and optical coherence tomography. Degenerative alterations in the retinotectal pathway of Ppt1−/−Sn−/− and Cln3−/−Sn−/− mice were significantly reduced. Ppt1−/−Sn−/− mice also showed a substantially improved clinical phenotype and extended lifespan, attenuated numbers of M1‐polarized microglia/macrophages and reduced expression levels of proinflammatory cytokines. This was accompanied by an increased frequency of CD8+CD122+ T‐lymphocytes in the CNS of Ppt1−/−Sn−/− mice, the regulatory phenotype of which was demonstrated by impaired survival of CD8+CD122− effector T‐lymphocytes in co‐culture experiments. We show for the first time that increased Sn expression on microglia/macrophages contributes to neural perturbation in two distinct models of CLN disease. Our data also indicate that a rarely described CD8+CD122+ T‐cell population can regulate the corresponding diseases. These studies provide insights into CLN pathogenesis and may guide in designing immuno‐regulatory treatment strategies. GLIA 2016;64:792–809
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 3×
“Recent studies have clearly demonstrated that microglia emerge from embryonic erythromyeloid precursor cells and are under normal conditions not renewed by hematopoietic myeloid cells (Greter and Merad, 2013; Prinz and Priller, 2014).”
BackgroundSiglec-mediated regulation of immune cell function in disease
Macauley, M. S., Crocker, P. R., & Paulson, J. C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3737 · Cited by 1,122
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713 · cited 2×
“Proinflammatory M1 polarized microglia/ macrophages can be neurotoxic (Aguzzi et al., 2013; Amor et al., 2014) and have been associated with juxtaparanodal axonal swelling and mitochondrial damage in a MOG-EAE model (Nikic et al., 2011).”
BackgroundMattapallil, M. J., Wawrousek, E. F., Chan, C.-C., Zhao, H., Roychoudhury, J., Ferguson, T. A., & Caspi, R. R. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9662 · Cited by 678
Dagher, N. N., Najafi, A. R., Kayala, K. M. N., Elmore, M. R. P., White, T. E., Medeiros, R., West, B. L., & Green, K. N. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0366-9 · Cited by 505 · cited 1×
“Moreover, CSF-1R inhibition can be used to block microglial/macrophage proliferation or eliminate microglia/macrophages in PNS and CNS diseases (Dagher et al., 2015; Klein et al., 2015).”
BackgroundMicroglia Versus Myeloid Cell Nomenclature during Brain Inflammation
Greter, M., Lelios, I., & Croxford, A. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00249 · Cited by 273 · cited 2×
“, 2013) we next investigated the expression of CD11c, a marker expressed by dendritic cells and activated microglia/macrophages (Greter et al., 2015).”
BackgroundRice, R. A., Spangenberg, E. E., Yamate-Morgan, H., Lee, R. J., Arora, R. P. S., Hernandez, M. X., Tenner, A. J., West, B. L., & Green, K. N. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0336-15.2015 · Cited by 270 · cited 1×
“Some studies also use Sn expression in order to identify peripherally derived infiltrating myeloid cells (Gao et al., 2015; Rice et al., 2015).”
BackgroundYou say lipofuscin, we say ceroid: Defining autofluorescent storage material
Seehafer, S. S., & Pearce, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.006 · Cited by 212
Regulation of microglia development and homeostasis.
Greter, M., & Merad, M. (2013) · Glia · doi:10.1002/glia.22408 · Cited by 141 · cited 3×
“Recent studies have clearly demonstrated that microglia emerge from embryonic erythromyeloid precursor cells and are under normal conditions not renewed by hematopoietic myeloid cells (Greter and Merad, 2013; Prinz and Priller, 2014).”
BackgroundRadke, J., Stenzel, W., & Goebel, H. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.007 · Cited by 122 · cited 2×
“…ceroid lipofuscinoses (CLN diseases; NCLs)comprise a group of lysosomal storage diseases initially characterized by selective neurodegeneration in the CNS, eventually culminating in widespread neuron loss, disability and early death (Boustany, 2013; Cooper et al., 2015; Radke et al., 2015).”
Background
Cited by
The rapidly evolving view of lysosomal storage diseases
Parenti, G., Medina, D. L., & Ballabio, A. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012836 · Cited by 230
Siglecs in Brain Function and Neurological Disorders
Siddiqui, S. S., Matar, R., Merheb, M., Hodeify, R., Vazhappilly, C. G., Marton, J., Shamsuddin, S. A., & Al Zouabi, H. (2019) · Cells · doi:10.3390/cells8101125 · Cited by 100
“In both these double knockouts, the neurodegeneration of the CNS was reduced, lifespan of mice was extended and the number of M1 polarized microglia were also reduced [82].”
BackgroundPathomechanisms in the neuronal ceroid lipofuscinoses
Nelvagal, H. R., Lange, J., Takahashi, K., Tarczyluk-Wells, M. A., & Cooper, J. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165570 · Cited by 80
Role and therapeutic implications of protein glycosylation in neuroinflammation
Rebelo, A. L., Chevalier, M. T., Russo, L., & Pandit, A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.01.004 · Cited by 50
Metadata
- Authors
- Groh, J., Ribechini, E., Stadler, D., Schilling, T., Lutz, M. B., & Martini, R.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2016-01-17
- Volume
- 64
- Issue
- 5
- Pages
- 792-809
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2346494156
- Cited by
- 52
- References
- 11
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.